Tepotinib
Merck
['lung', 'nsclc', 'tepotinib', 'lcsm,(-blcsm)', 'sclc']
#asco23 #lungcancer #lcsm #2010lcrfgrantee paul k. paik, md
long-term outcomes of tepotinib in patients with met exon 14 skipping nsclc from the vision study.
abstract: 9060 | poster bd #: 48 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.